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ABSTRACT 
one of the proteinase inhibitor's that has been 
studied in great detail is ovomucoid which contains three 
domains in a single polypeptide chain and which has been 
isolated from a large number of avian egg whites. In 
addition to ovomucoid, avian egg whites contain another 
serine proteinase inhibitor termed 'ovoinhibitor' which 
has attracted much less attention so far. However, 
recent cDNA sequencing studies have revealed its primary 
structure. On the basis of its sequence, ovoinhibitor has 
been proposed to contain seven domains in a single 
polypeptide chain, six of which are similar to the first 
and second domains of ovomucoid and the seventh domain is 
similar to ovomucoid third domain. Since each of these 
domains is small and is likely to represent one function, 
there is a great deal that can be learned about the 
structure ~ function relationship in proteins in general 
by studying these small well defined proteins. It was 
thought desirable to isolate the different domains of 
ovoinhibitor and study their physico-chemical and 
inhibitory properties and compare them with those of the 
different domains of ovomucoid. In this study, we report 
the isolation, purification and characterization of the 
first domain of ovoinhibitor. 
Chicken ovoinhibitor, which is usually associated 
with the crude preparation of ovomucoid, was isolated by 
subjecting the latter to salt fractionation followed by 
CM-cellulose chromatography. The preparation was found to 
be homogeneous both with respect to charge and size as 
indicated by analytical gel chromatography, sodium dodecyl 
sulphate polyacrylamide gel electrophoresis and 
polyacrylamide gel electrophoresis under native 
conditions. The inhibitor, isolated in this study, had an 
expected molecular weight of 53,000 and was found to 
contain 5% neutral carbohydrate and 0.54% sialic acid. 
The optical properties of ovoinhibitor were consistent 
with its aromatic amino acid content. 
Ovoinhibitor has one methionine residue (Met^^) 
located between domain I and II which renders it 
susceptible to specific chemical cleavage. The first 
domain of ovoinhibitor was isolated by subjecting the 
protein to cyanogen bromide cleavage at a protein to CNBr 
ratio of 1 : 2. After desalting, the digest was 
fractionated on a Sephadex G-75 column (2.4 x 86 cm) 
equilibrated with 0.01 M sodium phosphate buffer, pH 7.6. 
The protein fragment under the desired peak was 
identified as domain I on the basis of its fluorescence 
characteristics, molecular weight and amino acid 
composition. The fluorescence spectra of pooled fractions 
(iv) 
under the desired peak were recorded in 0.01 M sodium 
phosphate buffer, pH 7.6. Occurrence of excitation and 
emission maxima near 280 nm and 338 nm respectively was 
indicative of the presence of tryptophan. Since ovoinhibi-
tor contains only one tryptophan located in domain I, the 
fluorescence characteristics of protein under the desired 
peak were in aggrement with the fluorescence character-
istics of domain I. Further, the amino acid composition of 
the protein fragment was similar to that computed for 
domain I from amino acid sequence. The protein yield of 
domain I was about 11% (w/w) which is close to the 
theoretically expected value. 
Rechromatcgraphy of domain I on Sephadex G-75 column 
yielded a symmetrical elution profile. Further, the 
protein moved essentially as a single band in sodium 
dodecyl sulphate polyacrylamide gel electrophoresis and 
also in polyacrylamide gel electrophoresis under native 
conditions. These results taken together showed that the 
preparation is homogeneous with respect to size and 
charge. 
When the measured relative mobility of domain I 
(0.76) was compared with the relative mobilities of 
marker proteins namely ovalbumin, chymotrypsinogen A, 
ribonuclease A, cytochrome c_ and insulin which were 
(V) 
electrophoresed under identical conditions, the molecular 
weight of domain I was computed to be 8,3 00. The value 
of the molecular weight determined in this study (8,300) 
is about 12% higher than the value of molecular weight of 
domain I (7,300) deduced from amino acid sequence. This 
discrepancy in the molecular weight has been ascribed to 
the glycoprotein nature of domain I since it was found to 
contain 10% neutral carbohydrate and 2% sialic acid. Gel 
filtration behaviour of domain I was consistent with a 
Stokes radius of 1.7 nm and a frictional ratio of 1.28 
suggesting asymmetry and /or excessive hydration. 
The inhibitory activity of ovoinhibitor and domain I 
was measured against four proteinases namely bovine 
trypsin, bovine chymotrypsin, porcine elastase and 
proteinase K in 0.1 M Tris-HCl buffer, pH 8.0 containing 
0.01 M CaCl2. Ovoinhibitor inhibited all the four enzymes 
whereas its first domain was active only against trypsin. 
Domain I was virtually devoid of activity against 
chymotrypsin, elastase and proteinase K. Complete inhibi-
tion of trypsin was achieved at an inhibitor to enzyme 
molar ratio of 0.5 for ovoinhibitor and 1.0 for domain I 
suggesting that there are at least two trypsin 
inhibitory sites in ovoinhibitor, one of which is located 
in domain I. The equilibrium dissociation constant for 
domain I - trypsin complex was computed to be 1.5 x 10~^ M 
(vi) 
at pH 8.0. Further, the dissociation constant showed 
little or no dependence on pH, ionic strength and urea 
concentration suggesting that the complex is very stable. 
(vii) 
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INTRODUCTION 
Protein proteinase inhibitors are an important group 
of proteins capable of inhibiting the activity of 
proteolytic enzymes. They are ubiquitous and are found in 
all forms of life (Laskowski and Kato, 1980; Travis and 
Salvesen, 1983). Their primary function is to restrict 
and control the action of proteinases. Protein proteinase 
inhibitors of all the four major classes of proteinases 
namely serine proteinases, cysteine proteinases, acid 
proteinases and metallo proteinases, are known to occur in 
nature (Laskowski, 1986) . Protein inhibitors of serine 
proteinases have been most extensively studied. Depending 
upon amino acid sequence and disulphide bond topology, 
serine proteinase inhibitors have been classified into 
thirteen different families (Laskowski, 1986). These are 
listed in Table I. At least one member of each of these 
thirteen different classes of inhibitors has been studied 
in detail. The three dimensional structure of inhibitors 
belonging to ten of the thirteen different classes have 
been determined either by X-ray crystallography or by 2D 
NMR spectroscopy (Bode et al., 1985; Bode et al., 1987; 
Holak et al., 1989; Huber and Carrel, 1989). Availability 
of the detailed information has been very useful in 
understanding +-he molecular basis of inhibitory action. 
TABLE 
FAMILIES OF PROTEIN INHIBITORS OF SERINE PROTEINASES 
Animals 
1. Bovine pancreatic trypsin inhibitor (Kunitz) family^ 
2. Pancreatic secretory trypsin inhibitor (Kazal) family" 
3. Ascaris inhibitor family'^  
4. Serpin family (mechanistically distinct)° 
5. Hirudin family^ 
Plants 
6. Soybean trypsin inhibitor (Kunitz) family® 
7. Soybean proteinase inhibitor (Bowman Birk) family^ 
8. Potato 1 family^ 
9. Potato 2 family^ 
10. Barley trypsin inhibitor family 
11. Squash inhibitor family-^  
Microbial 
12. Streptomyces subtilisin inhibitor (SSI) family^ 
13. Other families 
a. Laskowski (1986). 
b. Laskowski et al. (1980). 
c. Babin ex: al. (1984). 
d. Carrell and Travis (1985). 
e. Hejgaard et al. (1983). 
f. Graham et al. (1985a). 
g. Graham et al. (1985b). 
h. Odani et al. (1983); Campas and Richardson (1983); 
Mahoney et al. (1984). 
i. Wieczorek et al. (1985); Joubert (1984). 
Protease inhibitors from egg white 
Egg white proteins are the principal solutes present 
in egg white, making up approximately 10% of its weight. 
They are globular proteins and most have acidic 
isoelectric points. Many are glycoproteins with 
carbohydrate contents ranging from 2 to 58%. Of the major 
egg white proteins, lysozyme is the only one having 
catalytic activity, but many have specific binding sites. 
A major group are those showing proteinase inhibitory 
activity and this inhibitory property was shown to be 
associated with the ovomucoid fraction (Meyer et al., 
1936; Lineweaver and Murray, 1947). 
Chicken ovomucoid, one of the major egg white 
proteins accounts for about 10% of the protein produced by 
the tubular gland ce]Is of the oviduct of laying hens 
(Palmiter, 1972) . Ovomucoid is a member of the Kazal 
family of serine proteinase inhibitors (Kato et al., 1976/ 
Laskowski and Kato, 1980). The chicken genome probably 
contains the genes for at least four Kazal inhibitors 
namely ovomucoid, ovoinhibitor, cystatin and ovostatin 
(Laskowski et al., 1980; Stevens, 1991). One of these 
inhibitors, ovoinhibitor (Matsushima, 1958), is alsq 
present in chicken egg v/hite but at about one tenth the 
amount of ovoir.jcoid (Liu et al., 1971). The synthesis and 
secretion of egg white proteins in the oviduct is 
hormonally controlled by oestrogen and progesterone and is 
also stimulated by insulin and dexamethasone (Kato et al., 
1988) . 
Ovoinhibitor from chicken egg white was first 
isolated by Matsushima (1958) and was shown to inhibit the 
activities of a bacterial proteinase from Bacillus 
subtilis and a fungal proteinase from Aspergillus oryzae. 
Rhodes et al. (1960) showed that ovoinhibitor inhibits 
bovine chymotrypsin and that the amino acid composition 
of ovoinhibitor was different from that of ovomucoid. The 
weak inhibition of chymotrypsin by commercial chicken 
ovomucoid prepared by the Lineweaver and Murray method 
(1947) was shown to be due to contamination with 
ovoinhibitor (Feeney et al., 1963). Matsuda (1983) showed 
that ovomucoid and ovoinhibitor share some common 
antigenic determinants. 
Distribution 
Ovoinhibitor has been isolated from several sources 
namely chicken, turkey, penguin and Japanese quail (Liu et 
al., 1971). Barrett (1974) found that chicken serum 
contained an antigen, 0C2 - protease inhibitor, which was-
immunologically identical to ovoinhibitor. Although the 
sequence of 0^ 2 - protease inhibitor is identical to that 
of egg white ovoinhibitor, the two have different 
isoelectric points. This may raise the possibility of the 
inhibitor having first been evolved as a plasma protein 
and later adapted to use in the egg as is the case with 
egg white conalbumin and serum transferrin (Thibdeau et 
al., 1978). 
Chemical properties 
(a) Amino acid composition 
Chicken ovoinhibitor contains 447 amino acid residues 
in a single chain with covalently bound carbohydrate 
moieties (Scott et al., 1987). The amino acid composition 
of ovoinhibitor reported by Davis et al. (1969) is given 
in Table II. Tiie second column in Table II gives the amino 
acid composition deduced from amino acid sequence (Scott 
et al., 1987). It is evident from the sequence data that 
the number of basic amino acid residues i.e. Lys, Arg and 
His is 65 and the acidic amino acid residues i.e. Asp and 
Glu is 56. The total number of hydrophobic amino acid 
residues is' 228 which form about 51% of the total amino 
acids. There are 19 proline residues. The inhibitor does 
not contain any free sulfhydryl group. The 42 cysteines 
form a series of 21 disuphide loops. Ovoinhibitor contains 
1 Trp, 19 Tyr and 7 Phe. There is considerable resemblance 
to the proportion of amino acids in ovomucoid (Feeney and 
Allison, 1969). 
TABLE II 
COMPOSITION OP CHICKEN OVOINHIBITOR 
Amino acid/carbohydrate 
Lysine 
Histidine 
Arginine 
residue 
Aspartic acid/Asparagine 
Glutamic acid/Glutamine 
Threonine 
Serine 
Proline 
Glycine 
Alanine 
1/2 Cystine 
Valine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Tryptophan 
Neutral sugar 
N-Acetyl glucosamine 
Sialic acid 
A. Davis et al. (1969). 
B. Scott et al. (1987). 
N.D. Not determined 
Residues/mole 
A 
23 
14 
21 
47 
39 
33 
27 
18 
32 
20 
34 
27 
4 
17 
22 
17 
6 
N.D. 
6-10 
8-14 
0.2-0.5 
B 
26 
16 
23 
27/24 
29/13 
35 
29 
19 
36 
22 
42 
30 
5 
19 
25 
19 
7 
1 
-
„ 
-
(b) Carbohydrate content 
The contant of carbohydrate in ovoinhibitor is much 
lesss than in ovomucoid (Feeney, 1971) . Chicken ovo-
inhibitor is heterogeneous with respect to carbohydrate 
content. Davis et al. (1969) separated ovoinhibitor into 
five components which have different sugar and sialic acid 
contents. Mosx: of the carbohydrate is present as N-acetyl-
D-glucosamine (Montgomery and Wu, 1963). 
Molecular properties 
The physico-chemical properties of ovoinhibitor are 
summarized in Table III. Ovoinhibitor from chicken egg 
white has been characterized for its molecular weight by 
different techniques and the values were found to range 
between 46,000 and 49,000. Using the results of primary 
sequence analysis (Scott et al., 1987), the precise 
molecular weight of protein part of ovoinhibitor molecule 
can be calculated as 49,000 neglecting the sugar moiety. 
Thus chicken ovoinhibitor is one of the higher molecular 
weight inhibitors of proteolytic enzymes compared to the 
trypsin inhibitor ovomucoid of 28,000 (Feeney, 1971) and 
to the chymotrypsin inhibitor from potato of 32,000 (Balls 
and Ryan, 1963). As the molecular weight of the inhibitor 
was found to be the same under native and denaturing 
conditions (Table III), it was concluded that the 
inhibitor consists of a single polypeptide chain (Davis et 
TABLE III 
PHYSICO-CHEMICAL PROPERTIES OF OVOINHIBITOR 
s. 
1. 
2. 
3. 
4'. 
5. 
6. 
7. 
Wo. Property 
Molecular weight 
Sedimentation 
constant*^ 
(S20W.X 10^3) 
Partial specific 
volume V^,ii:il/g) 
Emission maximum(nm) 
Specific extinction 
coefficient 
(E[g^) at 278 nm 
H-terminal^ 
C-terminal" 
Method 
Light scattering" 
Sedimentation 
(Archibald)^ 
Sedimentation 
equi1ibr ium '^' 
Sedimentation 
equilibrium® 
Amino acid ^ 
composition 
SDS - PAGE^ 
Amino acid 
composition^' 
Density*^ 
,d 
Value 
49,000 
44,000 
48,600-48,700 
52,400 
46,000-49,000 
48,000 
3.3 
0.693-0.712 
0.707 
340 
7.4^,6.5-6.9^ 
Valine 
Cysteine 
b. Davis et al. (1969). 
c. Davis et al. (1969). In H2O and D2O. 
d. Davis et al. (1969). In 6 M guanidinium chloride 
containing 2 mM dithiothreitol, pH 8.0. 
e. Feinstein (1970). 
f. Davis et al. (1969). Molecular weight range for 
five fractions was calculated as follows : amino 
acids 44,000 + hexose 800-1800 + glucosamine 1500-
3000. 
g. Liu et al. (1971). 
h. Scott et al. (1987) . 
al,, 1969). 
Primary structure 
The amino acid sequence of ovoinhibitor as deduced 
from cDNA (Scott et al., 1987) is given in Fig. 1. The 
gene structure of .chicken ovoinhibitor, a seven domain 
Kazal serine proteinase inhibitor was determined using RNA 
blot hybridization analysis. The gene was identified 
initially as a region 9-23 kilobases upstream of the gene 
for the related inhibitor ovomucoid. Ovoinhibitor RNA 
appears in oviduct and liver. cDNA were identified by 
screening an oviduct cDNA library with a nick-translated 
DNA restriction fragment which contained an exon of the 
gene. Analysis of cDNA of ovoinhibitor suggested that the 
gene is about 10.3 kilobases in length and consists of 16 
axons. Each Kazal domain is encoded by two exons (Stein et 
al., 1980). Like ovomucoid, introns fall between the 
coding sequences of the ovoinhibitor domains, an 
arrangement which may have facilitated domain duplication. 
The intradomain intron occurs in an identical position in 
all the ovoinhibitor and ovomucoid Kazal domains (see 
Fig.2) suggesting that this intron was present in the 
primordial inhibitor gene. The arrangement of exons in the 
inhibitor was shown to be identical to that of the human 
pancreatic secretory trypsin inhibitor (hPSTI) (Tan et 
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Domain I Domain V 
Domain IV 
Domain VII 
Fig. 1: Amino acid sequence of chicken ovoinhibitor as 
obtained by cDNA studies (Scott et al., 1987). 
The structure of seven Kazal domains of 
ovoinhibitor is drawn to emphasize the 
similarities. The disulphide bonds are indicated 
by solid lines. The positions of the introns 
which interrupt the coding sequences of the 
domains are shown with arrows. The P, amino 
acids of the domains are indicated by 
asterisks. 
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Fig. 2: Comparative structure of the peptide coding 
regions of the chicken ovoinhibitor and 
ovomucoid genes. 
The segments of ovoinhibitor (left) and 
ovomucoid (right) genes that code for the signal 
peptide plus the first two amino acids of the 
mature protein, 'a' domains and 'b' domains are 
indicated in lines 1-4 respectively. Exons are 
shown as boxes with the length in nucleotides 
within or above the box. Introns are drawn as 
lines with the length indicated above or below 
the line. 
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al.,, 1988). 
Based on internal homology and position of twenty one 
disulphide bonds in the sequence, a structural model of 
ovoinhibitor has been proposed. Ovoinhibitor consists of 
seven domains in a single polypeptide chain (see Fig.l). 
The first six (a-type) domains are more closely related to 
each other than to the seventh (b-type) domain (see 
Fig.3A). The third domain is unusual in that all of the 
other 'a' domains are more related to the third domain 
than to any other 'a' domain. This homology suggests that 
domain III may have evolved at a slower rate relative to 
the other 'a' domains. Each domain contains six cysteines 
in similar locations that form three intradomain 
disulphide bonds. The seventh domain of ovoinhibitor is 
distinguished from the first six domains by a shorter 
peptide between cysteines I and II. Structurally, the 
first six domains of ovoinhibitor are more closely related 
to domain I and II of ovomucoid (see Fig.3B). The seventh 
domain of ovoinhibitor is homologous to the third domain 
of ovomucoid. These observations are consistent with the 
proposal that the ovoinhibitor and ovomucoid genes have 
descended from a gene that coded for one 'a' and one 'b' 
Kazal domain (Scott et al., 1987). Three glycosylation 
sites have been identified in ovoinhibitor by Yet and Wold 
(1990) which have very similar but not identical glycans; 
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Fig. 3: Comparison of the ovoinhibitor domains to each 
other (A) and to the ovomucoid domains (B). 
(A) The percent homology between the 
aligned DNA-coding sequences of the ovoinhibitor 
domains is shown above the diagonal. The 
percent homology between the aligned amino acid 
sequences of the ovoinhibitor domains is shown 
below the diagonal. 
(B) The percent homology between the 
aligned amino acid sequences of the ovomucoid 
and ovoinhibitor domains is shown to the left of 
the middle vertical line. The percent homology 
between the aligned DNA-coding sequences of the 
ovoinhibitor and ovomucoid domains is shown to 
the right of the vertical line. The percent 
homologies between two domain sequences were 
calculated by dividing the number of matches by 
the number of amino acids or nucleotides in the 
longest of the two domains. 
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they are however significantly different from those 
observed in the single site of ovotransferrin. 
Yamamoto et al. (1985) have reported the sequence of 
a cDNA clone encoding the human pancreatic secretory 
trypsin inhibitor (hPSTI), a single domain Kazal serine 
proteinase inhibitor. The ovoinhibitor and ovomucoid 
putative signal peptide sequences are more closely 
related to each other (46% amino acid, 55% nucleotide 
homology) than to the putative signal peptide sequences of 
hPSTI (26 and 21% amino acid, 43 and 40% nucleotide 
homology for ovoinhibitor and ovomucoid, respectively). 
Moreover, the Kazal domain sequence of hPSTI (positions 7-
58 of mature protein) have similar homology (28-37% amino 
acid, 40-45% nucleotide) to each of the 'a' and 'b' type 
domains of ovoinhibitor and ovomucoid. These observations 
suggest that the ovomucoid-ovoinhibitor and hPSTI 
ancestral genes diverged prior to the duplication that 
generated th^ i primordial 'a' and 'b' domains of 
multidomain Kazal inhibitors. 
X-ray crystal structure of ovomucoid third domains 
The three dimensional structure of the Kazal 
inhibitors, bovine pancreatic secretory trypsin inhibitor 
(Bolognesi et al., 1982), and third domains of Japanese 
quail (Papamokos et al., 1982), turkey (Read et al., 1983) 
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and of silver pheasant (Bode et al., 1985) have been 
determined by X-ray crystallography. All contain similar 
elements of secondary structure, a triple stranded anti-
parallel p sheet and an oc helix. The reactive sites, which 
have a similar geometry but are not part of the p sheet or 
oC helix, occur near the surface of the protein. In these 
inhibitors, the oC helix is followed by a surface loop. As 
the structures of these relatively divergent inhibitors 
are very similar, it seems reasonable to assume that the 
more closely related chicken ovomucoid and ovoinhibitor 
domains would have structures which are similar to that of 
Japanese quail, turkey and silver pheasant ovomucoid third 
domains. Ogino et al. (1982) did extensive nuclear 
magnetic resonance studies on the third domains of 
ovomucoid and found that all of them behave as rigid, 
native, globular proteins and not as random structures or 
denatured polypeptides. 
Inhibition specificity 
Chicken ovoinhibitor has an unusually broad spectrum 
of inhibitory activities. First, this inhibitor was 
distinguished from ovomucoid because it inhibits bacterial 
and fungal proteinases in addition to bovine trypsin 
(Matsushima, 1958; Rhodes et al., 1960). This inhibitor 
also inhibits bovine chymotrypsin (Ryan and Clary, 1964; 
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Ryan et al., 1965), components of pronase (Haynes and 
Feeney, 1967), porcine elastase (Gertler and Feinstein, 
1971) and proteinase K (Kato and Kohr, 1978). Birk et al. 
(1983) showed that chicken ovoinhibitor also inhibits 
protease F, a bacterial enzyme with chymotrypsin and 
elastase like specificities. However, the ovoinhibitor 
from penguin egg white does not inhibit Cxi - chymotrypsin 
(Liu et al., 1971). 
For bovine trypsin and chymotrypsin, ovoinhibitor-
enzyme molar combining ratio was found to be about 1 : 2 . 
(Gertler and Ben Valid, 1980). The reactive sites for 
bovine trypsin and chymotrypsin (or subtilisin) are 
independent and non-competitive (Tomimatsu et al., 1966; 
Davis et al., 1969; Liu et al., 1971). However, the two 
binding sites for trypsin and probably also for 
chymotrypsin differ in their affinity towards the 
respective enzyme (Gertler and Ben Valid, 1980). 
Chicken ovoinhibitor inhibits the esterolytic, 
proteolytic and elastolytic activities of porcine 
elastase. In most cases of inhibition of porcine elastase, 
only the non-specific proteolytic activity was inhibited 
while the elastolytic activity was unchanged. The 
formation of the complex between elastase and ovoinhibitor 
was demonstrated as one to one by means of electrophoresis 
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at pH 6.9 (Gertler and Feinstein, 1971). 
The complex of porcine elastase with ovoinhibitor 
inhibits one mole of trypsin and chymotrypsin but does not 
inhibit the alkaline proteinase from Aspergillus oryzae 
(Gertler and Feinstein, 1971). The complex of alkaline 
proteinase with inhibitor does not inhibit porcine 
elastase. Therefore, from this experiment it was concluded 
that ovoinhibitor has at least three types of binding 
sites, one for trypsin, another for chymotrypsin and the 
third one for either elastase or alkaline proteinase from 
fungus. 
Chemical modification of the inhibitor revealed some 
interesting information. Oxidation of methionine residues 
of chicken ovoinhibitor with N-chloro succinamide resulted 
in a selective loss of its inhibitory activities (Shecter 
et al., 1977). While trypsin inhibitory activity was not 
afftscted at all, half of the chymotrypsin inhibitory 
activity and all of the elastase inhibitory activity was 
lost. The 50% loss of the chymotrypsin inhibitory activity 
resulted from the inactivation of one of its two 
chymotrypsin-inhibiting sites rather than from a decrease 
in the binding constants for both sites. Later, it was 
found that the chymotrypsin binding site that is not 
modified by mild oxidation, is also capable of binding 
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elastase II (Vered et al., 1981). 
Nitrophenyl-sulfanylation of the single tryptophan 
residue of ovoinhibitor did not affect its inhibitory 
activity at all (Shecter et al., 1977). Reductive 
methylation of amino group of ovoinhibitor had no effect 
on its trypsin, chymotrypsin and subtilisin inhibitory 
activities (Liu et al., 1971). Modification of arginine 
residues in the inhibitor with 1,2-cyclohexanedione 
abolished its trypsin inhibitory activity (Liu et al., 
1971). 
Recently it was shown that thioredoxin, reduced 
either enzymatically with NADPH and NADP-thioredoxin 
reductase or chemically with dithiothreitol, reduced 
trypsin inhibitor proteins from several sources. Among 
these were the cysteine rich ovomucoid and ovoinhibitor 
proteins (Kobrehel et al., 1991). 
Reactive sites 
The sequence surrounding the vicinity of the reactive 
sites of the seven domains of chicken ovoinhibitor is 
shown in Fig. 4. In the first four domains, the P, residue 
has been found to be Arg. In the sixth and seventh 
domains, the critical residue is Met whereas P, of the 
fifth domain is Phe. In Japanese quail ovoinhibitor, the 
Phe at P^ position of the fifth domain is replaced by 
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Trypsin. 
Trypsin. 
Trypsin. 
Trypsin. 
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Chymotrypsin. 
Sublilisin. 
Elostose. 
Proteinase K 
Fig. 4: Amino acid sequences surrounding the reactive 
sites of the domains of chicken and Japanese 
quail ovoinhibitors. 
CH refer's to chicken ovoinhibitor 
and JQ to Japanese quail ovoinhibitor; 
1,2,3, and 7 refer to first to seventh 
domains respectively. Solid line on Japanese 
quail sequence indicate identical amino acid 
residues with chicken ovoinhibitor residues. 
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another aromatic amino acid namely Tyr. This suggests that 
the first four domains (I-IV) have the potential reactive 
sites for trypsin and remaining three domains have the 
potential reactive sites for chymotrypsin-like enzymes. 
Mechanism of interaction with enzyme 
In contrast to other inhibitors, the mechanism of 
interaction of protein inhibitors of serine proteinases 
with their cognate enzymes is known in considerable detail 
(Laskowski and Kato, 1980). Eleven of the serine 
proteinase inhibitor families defined in Table I interact 
according to the standard mechanism described below. 
In each inhibitor molecule, there exists on the 
surface, at ]east one (more in multiheaded inhibitors) 
peptide bond called the reactive site (Ozawa and 
Laskowski, 1966; Laskowski and Sealock, 1971) which 
specifically interacts with the active site of the enzyme 
in a substrate like manner. Paradoxically, the inhibitors 
are frequently superb substrates when judged by k^ ^^ /K^ ^ 
criterion. But both the k^^^ and Kj^  values are many orders 
of magnitude lower than the values for normal substrates 
(Laskowski and Kato, 1980) . Thus inhibitors act as 
inhibitors, not as substrates. 
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standard mech&nism 
Earlier, Kunitz (1947) suggested that inhibitor (I) 
combines with enzyme (E) in 1 : 1 stoichiometry to form a 
totally inactive complex (C) according to the equation : 
'^ on 
E + I ^ — — " ^ C (1) 
•^ off 
It is a common error to claim that the complex 
possesses some residual activity. There are two reasons 
for this mistaken view - one is that, under some assay 
conditions, part of the complexes are allowed to 
dissociate and, thus, exhibit activity; the other is that 
occasionally a complex is made from an enzyme slightly 
contaminated by another enzyme which is not cognate and, 
thus, the contaminant enzyme's activity is seen in the 
complex. 
The afore mentioned scheme however does not provide 
any molecular details of complex formation. Laskowski's 
group (Lebowitz and Laskowski, 1962; Finkenstadt and 
Laskowski, 1905; Ozawa and Laskowski, 1966; Finkenstadt 
and Laskowski, 1967; Luthy et al., 1973) found that the 
inhibitor was modified after the reaction. Therefore the 
mechanism was more correctly stated as: 
^on^ ^ offv * 
E + I ^ — — ^ c ^ - - — i ^ E + I (2) 
'^ off ^ on 
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where the symbols have the same meaning as before 
except for the newly introduced I , which is called 
modified inhibitor and I which is rechristened virgin 
inhibitor. Virgin inhibitor has all of its peptide bonds 
intact whereas modified inhibitor has one peptide bond, 
the reactive site peptide bond, hydrolyzed. Here k^ j^  and 
k-j- refer to the second order association rate constants 
for enzyme and virgin inhibitor and enzyme and modified 
inhibitor respectively; k^ ^^  and k^^j are the first order 
dissociation rate constants of the enzyme inhibitor 
complex to free enzyme and virgin or modified inhibitor 
respectively (Laskowski et al., 1981). 
Since the complex may exist in more than one 
conformation under varying experimental conditions, the 
above mechanism was further modified to give rise to what 
Laskowski and Kato (1980) referred to as the ^standard 
mechanism' : 
E + I ^ --- L -^-•- C ^ --^  X ^ --^  L* -.^.-"^  E + I* (3) 
where L, X and L are loose, non-covalent 
intermediates and C is a stable 1:1 enzyme inhibitor 
complex. The number of conformational states of the 
complex may be more than that described by equation (3). 
The simplest Kunitz mechanism described above is 
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s t i l l used for most association constant (Kg) 
measurements. 
Equation (1) yields : 
K . -- = - i - 1 - = - S D - (4) 
^ Kd [ I ] [E] k^ff 
As stated above, the amino acid sequence of 
ovoinhibitor shows internal sequence homology suggesting 
the existence of seven structural domains. The first six 
domains of ovoinhibitor are structurally similar to the 
first and second domains of ovomucoid whereas the seventh 
domain of ovoinhibitor is similar to ovomucoid third 
domain. It is conceivable that all the seven domains 
possess independent inhibitory activity. Further each 
domain of ovoinhibitor may represent independently folded 
structures. Information on these possible aspects of 
domain structure can be made available by investigating 
the structure - function relationship of individual 
domains. An essential prerequisite for such studies is 
the isolation of the separate domains of ovoinhibitor. In 
this thesis, the isolation, characterization and 
inhibitory properties of domain I of ovoinhibitor have 
been reported for the first time. 
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EXPERIMENTAL 
A. MATERIALS 
1. Proteins 
Bovine serum albumin (lot no. lOOF-0249), ovalbumin 
(lot no. 105C-8022), chymotrypsinogen A (lot no. 40F-
8050), cytochrome c (lot no. 09C-0088), myoglobin (lot 
no. 85C-0138), ribonuclease A (lot no. 84F-8145), bovine 
trypsin type II (lot no. T-8128), bovine oC-chymotrypsin 
(lot no. 2OH-0O25) and porcine elastase type I (lot no. E-
120) were purchased from Sigma Chemical Company, St. 
Louis, Mo., USA. Proteinase K (lot no. 12799321-27/July 
92) was from Boehringer Mannheim GmbH, Germany. 
Commercially available insulin from Boots Pharmaceuticals 
Ltd., Bombay, India was dialyzed extensively against 
buffer before use. 
2. Substrates for assay of proteolytic enzymes 
Alpha-N-benzoyl-DL-arginine-p-nitroanilide (BAPNA) 
(lot no. T-16) which was used in the assay of trypsin was 
obtained from CSIR Centr«?. for Biochemicals, Delhi, India. 
The specific synthetic substrate for chymotrypsin, 
succinyl-Ala-Ala-Pro-Phe-p~nitroanilide (Suc-AAPF-pNA) 
(lot no. 80H-58301) was purchased from Sigma Chemical 
Company, St. Louis Mo., USA. Casein was isolated from 
skimmed milk by acid precipitation followed by washing 
with alcohol and ether. 
3. Column Qhromatographla m«dl« 
Carboxymethyl cellulose (lot no, C~2883) was obtained 
from Sigma Chemical Company, St. Louis, Mo., USA. Sephadex 
G-75, Sephadex G-25 and Blue Dextran 2000 were purchased 
from Pharmacia Fine Chemicals, Uppsala, Sweden. 
4. Reagents used for gel electrophoresis 
Reagents used in electrophoresis with their sources 
in parentheses were : acrylamide (E. Merck, Dramstadt, 
Germany), N-N'-methylene bisacrylamide (Reanal, Budapest, 
Hungary), N,N,N',N'-tetramethylethylenediamine (Ferak, 
Berlin, Germany), ammonium persulphate (E. Merck, 
Dramstadt, Germany), riboflavin (E. Merck, Dramstadt, 
Germany), and dichlorodimethyl silane (BDH, Poole, 
England), sodium dodecyl sulphate (BDH, Bombay, India) and 
coomassie brilliant blue R-250 (Sigma Chemical Company, 
St. Louis, Mo., USA). Glycerol, sucrose, isopropanol and 
chloroform were obtained from BDH, Bombay, India. 
5. Miscellaneous reagents 
Cyanogen bromide and Tris (hydroxymethyl) amino 
methane were purchased from Sisco. Res. Lab., Bombay, 
India, whereas N-acetylneuraminic acid was from Sigma 
Chemical Company, St. Louis, Mo., USA. Phenol, sodium 
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metaperiodate, sodium arsenate, thiobarbituric acid, 
sodium sulphate, cyclohexanone, galactose and dimethyl 
sulphoxide were obtained from BDH, Bombay, India. The rest 
of the chemicals used were of analytical grade. 
Glass distilled water was used throughout these 
studies. 
B. METHODS 
1. Measurement of pH 
Elico digital pH meter, model Ll-122, was used for pH 
measurement in conjunction with Elico combined electrode 
at room temperature. The pH meter was standardized with 
0.05 M potassium hydrogen pthalate buffer, pH 4.0 in the 
acidic range and with 0.01 M sodium tetraborate buffer, pH 
9.2 in the basic range. 
2. Optical measurements 
Absorbance in the visible range was measured on a 
AIMIL Photochem-8 colorimeter. In the ultraviolet region, 
light absorption measurements were performed on Cecil UV-
spectrophotometer, model CE 202 and on Cecil UV-double 
beam spectrophotometer, model CE 594 using silica cells of 
1 cm path length. Fluorescence measurements were carried 
out on Shimadzu spectrofluorometer, model RF-540, in 
conjunction with fitted Shimadzu Data Recorder, DR-3, at 
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room temperature. The slit width was maintained at 10 nm 
throughout these measurements. 
3. Determination of protein concentration 
Protein concentration was determined either by the 
method of Lowry et al. (1951) or by spectrophotometric 
method. 
(a) Lowry's method 
To one ml of protein solution was added 5 ml of 
copper reagent and after mixing the solution, it was 
allowed to stand for 10 minutes at room temperature. Then 
1 ml of Folin-phenol reagent was added to the mixture and 
the contents were mixed well. The mixture was incubated 
for 3 0 minutes and the colour intensity was read at 700 
nm. A calibration curve between optical density at 700 nm 
and protein concentration in milligram was obtained by the 
method of least squares, using bovine serum albumin as 
standard. The linear curve was found to fit the equation : 
(O.D.)7QQ^ j^  = 1.97 (mg, protein) + 0.04 (5) 
(b) Spectrophotometric method 
In a few experiments, the protein concentration was 
determined by measuring the optical density of protein 
solution in 0.1 M Tris-HCl buffer, pH 8.0 containing O.OIM 
CaCl2, using appropriate values of specific extinction 
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coefficient, E^ ^^ j^  at 280 nm. The values used were : 
trypsin, 15.4 (Walsh, 1970), chymotrypsin, 20.4 (Wilcox, 
1970), proteinase K, 14.2 (Ebeling et al., 1974), 
elastase, 20.2 (Shotton, 1970) and ovoinhibitor, 6.75 
(Davis et al., 1969). 
4. Chromatography 
{&) Ion exchange chromatography 
Ovoinhibitor was purified by CM-cellulose chromato-
graphy. In order to regenerate the resin, it was treated 
with one litre of 0.1 M hydrochloric acid and then washed 
extensively with distilled water. After this, the ion-
exchanger was treated with one litre of 0.1 M sodium 
hydroxide and washed extensively with water till the pH of ' 
the washings became neutral. The exchanger was packed into 
a column (2.5 x 4 cm) and subsequently equilibrated with 
0.1 M ammonium acetate buffer, pH 4.0. 
(b) Sephadex gel chromatography 
The first domain of ovoinhibitor was isolated on a 
Sephadex G-75 column (2.4 x 86 cm) which was packed 
according to the method of Ansari and Salahuddin (1973). 
The homogeneity of packing was checked by passing a band 
of 0.02% (w/v) solution of Blue Dextran through the 
column. The elution volume (Vg) of Blue Dextran yielded 
the void volume (V^ ) of the column. As can be seen in 
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Fig. 5, the dye eluted from the column as a symmetrical 
peak with an elution volume of 123 ml. In order to 
determine the inner volume, Vj^ , of the column, glucose, 
for which distribution coefficient, K^, would be unity was 
passed through the column (see Fig. 6) . The elution 
volume of glucose, Vg,g is given by the equation: 
Ve'^ = V^ + K^ Vi (6) 
Thus the inner volume, V^ of the column was computed 
with the help of equation (6), to be 237 ml. The total 
volume of the column, V^, was determined to be 388 ml. 
The column was equilibrated with 0.01 M sodium phosphate 
buffer, pH 7.6 containing 0.02% (w/v) sodium azide and 
operated at a flow rate of 30 ml/hr. 
5. Polyacrylamide gel electrophoresis 
Polyacrylamide gel electrophoresis of ovoinhibitor 
and domain I was performed in Tris-glycine buffer, pH 8.2 
(ionic strength = 0.02) according to the method of Davis 
(1964). The gel tubes (0.5 x 9 cm) were washed with 
detergent, chromic acid and then with distilled water. 
After drying, the tubes were siliconized with 5% 
dichlorodimethyl silane in chloroform. A small pore 
solution was prepared which contained 7% (w/v) acrylamide, 
0.18% (w/v) N,N'-methylene bisacrylamide, 0.03% (v/v) 
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Fig. 5s Elution profile of Blue Dextran on Sephadex G-7 5 
column. 
• About 10 mg of the sample was applied to 
the column (2.4 x 86 cm) equilibrated with O.OIM 
sodium phosphate buffer, pH 7.6 and eluted in 
3 ml fractions at a flow rate of 30 ml/hr. The 
colour intensity was read at 610 nm. 
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Fig. 6: Elution profile of glucose on Sephadex G-75 
column. 
About 10 mg of the sample was applied to 
the column (2.4 x 86 cm) equilibrated with O.OIM 
sodium phosphate buffer, pH 7.6 and fractions 
of 5 lal each were collected at a flow rate of 30 
ml/hr. The column was monitored by the method 
of Dubois et al. (1956). 
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N,N,N',N'-tetraniethylethylenediainine (TEMED) and 0.07% 
(w/v) ammonium persulphate. To each tube, 2 ml of small 
pore solution was added and the surface was carefully 
layered with a few drops of water. After 30 minutes of 
polymerization, 0.5 ml of large pore solution was added to 
each tube. The latter contained 2.5% (w/v) acrylamide, 
0.62% (w/v) riboflavin and 20% (w/v) sucrose. The 
solution was photopolymerized under fluorescent light for 
15 minutes. The protein sample was prepared by adding two 
drops of glycerol to one ml of protein solution having a 
concentration of 1 mg/ml. About 80-100 pg of protein was 
applied and electrophoresed for 3-4 hr with a current of 
2-5 mA per tube. The gels were stained with a solution of 
1% (w/v) amidoschwarz in 7% (v/v) acetic acid and 
destained mechanically with 7% (v/v) acetic acid. 
6. Sodium dodecyl sulphate polyacrylamide gel 
electrophoresis 
ESodium dodecyl sulphate (SDS) polyacrylamide gel 
electrophoresis was performed according to the method of 
Weber and Osborn (1969) in 0.1 M sodium phosphate buffer, 
pH 7.0 containing 0.1% (w/v) SDS. After washing the glass 
tubes (0.5 X 9 cm) with chromic acid and detergent, these 
were siliconized with 7% dichlorodimethyl silane in 
chloroform. The tubes were mounted vertically in a stand 
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with their lower ends closed with rubber stoppers. About 2 
ml of the solution containing 12.5% (w/v) acrylamide, 
0.18% (w/v) N,N'-methylene bisacrylamide, 0.03% (v/v) 
N,N,N',N'-tetramethylethylenediamine (TEMED), 0.07% (w/v) 
ammonium persulphate and 0.1% (w/v) SDS was poured in each 
tube and the surface was layered with a few drops of 
water. The solution was polymerized for 30 minutes at room 
temperature. 
For the preparation of sample, the protein was 
dialyzed against 0.01 M sodium phosphate buffer, pH 7.0 
containing 1% (w/v) SDS and to it were added a few drops 
of glycerol and one drop of 0.01% (w/v) bromophenol blue. 
An appropriate volume of this mixture (0.05-0.1 ml) 
containing 60-80 ug of protein was then applied to the gel 
tubes. The electrophoresis was carried out for 6-7 hr in 
0.1 M sodium phosphate buffer, pH 7.0 using a current of 6 
mA per tube: The gels were removed from the gel tubes with 
the help of a long needle attached to a syringe. These 
were then stained with 0.2% (w/v) coomassie brilliant blue 
R-250 dye in 25% (v/v) methanol and 10% (v/v) acetic acid 
and destained mechanically with 10% (v/v) acetic acid. The 
relative mobility I^ of the proteins were calculated by 
the standard procedure. 
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7. Determination of carbohydrate content 
(a) Neutral carbohydrate 
The neutral carbohydrate of ovoinhibitor and domain I 
was estimated by the method of Dubois et al. (1956) using 
galactose as standard. To 1 ml of protein solution was 
added 1 ml of 2% (w/v) phenol and 5 ml of concentrated 
sulphuric acid. The mixture was incubated for 15 minutes 
and the colour intensity measured at 490 nm against an 
appropriate blank of bovine serum albumin. A calibration 
curve between carbohydrate concentration in milligram and 
absorbance at 490 nm was obtained by the method of least 
squares. The linear curve (see Fig. 7) fits the equation : 
i^^-^') /^SOim ~ ^'^^ ^^ '3' galactose) + 0.056 (7) 
(b) Sialic acid 
The sialic acid content of ovoinhibitor and domain I 
was estimated by the method of Warren (1959), using N-
acetylneuraminic acid as standard. The following solutions 
were prepared : (a) 0.2 M sodium metaperiodate in 9 M 
orthophosphoric acid (b) 10% (w/v) sodium arsenate in a 
solution of 0.5 M sodium sulphate and 0.1 M HjSO^ (c) 0.6% 
(w/v) thiobarbituric acid in a solution of 0.5 M sodium 
sulphate. First, the protein was treated with 0.1 M HjSO^ 
and heated in a boiling water bath for one hr to release 
the sialic acid. For the determination of sialic acid, 0.5 
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Fig. 7: Calibration curve for the estimation of neutral 
carbohydrate by the method of Dubois et al. 
(1956). 
Galactose was used as the standard. The 
straight line computed by the help of least 
squares, fits the equation: 
(O.D.)490nm ~ ^'^^ ('"^' galactose) + 0.056 
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ml of the protein solution was mixed with 0.1 ml of 0.2 M 
sodium metaperiodate and incubated for 20 minutes at room 
temperature. Then 1 ml of 10% (w/v) sodium arsenate was 
added with continuous shaking until a yellow colour, which 
appeared momentarily, disappeared. After this, 3 ml of 
0.6% (w/v) thiobarbituric acid was added and the mixture 
was heated for 15 minutes in a boiling water bath. After 
cooling, equal volume of cyclohexanone was added and the 
colour intensity of the cyclohexanone layer was read at 
550 nm using an appropriate blank. 
A calibration curve was obtained with N-acetyl-
neuraminic acid (see Fig. 8) and the linear curve was 
found to fit the equation : 
(O.D. ) 55Q^ jj, = 0.037 (vig, sialic acid) + 0.03 (8) 
8. Determination of inhibitory activity 
The inhibitory activity of ovoinhibitor and domain I 
was measured against four proteinases namely trypsin, 
chymotrypsin, elastase and proteinase K, Thi^  substrates 
used were BAPNA for trypsin, Suc-AAPF-pNA for chymotrypsin 
and casein for elastase and proteinase K. The enzyme 
induced hydrolysis of BAPNA and Suc-AAPF-pNA produced p-
nitroanilide (pNA) which absorbed maximally at 410 nm. The 
absorbance at 410 nm was taken to represent the 
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Fig. 8: Calibration curve for the estimation of sialic 
acid by the method of Warren (1959). 
N-Acetylneuraminic acid was used as the 
standard. The straight line computed by the help 
of least squares, fits the equation: 
(O.D.)55Q ^^ = 0.037 (vig, sialic acid) + 0.03 
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concentration of the hydrolyzed product. A fixed 
concentration of enzyme was incubated with different 
concentrations of ovoinhibitor or domain I in 0.1 M Tris-
HCl buffer, pH 8.0 containing 0.01 M CaCl2 for 3 0 minutes 
at 37° C. The residual enzyme activity was measured as 
described in the references below with the final substrate 
concentration as follows : for trypsin catalyzed 
hydrolysis of BAPNA (Erlanger et al., 1961) final 
concentration of BAPNA was 0.8 mM whereas for chymotrypsin 
catalyzed hydrolysis of Suc-AAPF-pNA (Del Mar et al., 
1979) final concentration was 0.1 mM substrate. 
The proteinase activity of elastase and proteinase K 
was determined by Anson's (1938) method using acid 
precipitated casein as substrate. The enzyme was incubated 
with different concentrations of ovoinhibitor or domain I 
in 0.1 M Tris-HCl buffer, pH 8.0 containing 0.01 M CaCl2 
for 3 0 minutes at room temperature. To the mixture was 
then added 1 ml of 0.5% (w/v) casein and the resulting 
solution was incubated for 1 hr at 37 C. After 
precipitation with 6% (w/v) TCA, the solution was filtered 
and the TCA soluble fraction assayed by the method of 
Lowry et al. (1951). The proteinase activity was measured 
both in presence and absence of inhibitor. 
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9. Determination of amino acid composition 
Amino acid analysis of domain I of ovoinhibitor was 
carried out in the laboratory of Prof. M. A. Siddiqui, at 
the German Cancer Research Centre, Heidelberg, Germany, 
using PITC chemistry on an automatic derivatizer Model 
420A (Applied Biosystems) connected to an on-line HPLC 
Model 130A. 
The amino acids were derivatized as PTC amino acids 
and fractionated by HPLC using 0.05 M sodium acetate 
buffer, pH 5.5 and 70% acetonitrile solution. The general 
purpose column C-18 was used in the analysis. 
(a) Preparation of sample 
About 200 v>g of protein sample (0.1 mg/ml) was taken 
in a stoppered 9-mm tube and dried on a lyophilizer» The 
dried sample was dissloved in 6 N constant boiling 
hydrochloric acid. A small amount (one or two drops) of p-
mercaptoethanol and 0.1% (w/v) phenol were added to the 
sample to prevent the destruction of methionine and 
aromatic amino acids respectively. Nitrogen gas treated 
with pyrogallic acid in 4 N NaOH was then flushed through 
the sample. The nitrogen supply was finally turned off and 
the tube was sealed immediately. Following hydrolysis of 
o 
the sample at 110 C for 24 hr, the sealed ampule was 
opened and dried under vacuum. The residue was then 
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dissolved in 100 \il of loading buffer. 
(b) Analysis of sample 
About 10 \il of protein sample was injected into the 
sample loop of the derivatizer. The derivatization 
chemistries are automatically performed through commands 
stored as either standard or user defined cycles. With the 
reaction complete, the derivative was then directly 
transferred to the HPLC unit for analysis, using the 
factory installed elution gradient stored as programme #2. 
At the end of the programme, the chromatogram chart was 
removed from the recorder. Similarly, a chromatogram was 
obtained with the calibration mixture of standard amino 
acids supplied by LKB, England. The area per mole (C^y^) 
was computed for the standard sample of amino acid and the 
number of an amino acid in the protein sample was 
calculated by dividing the area corresponding to that 
amino acid by C^^^ factor found for that amino acid as 
described earlier (Khan, 1982). 
10. Isolation and purification of ovoinhibitor 
First, ovomucoid was isolated from eggs of white leg 
horn by the method of Kato et al. (1987) . To chicken egg 
white, two volumes of freshly prepared, cold precipitating 
solution (1 volume of 0.5 M trichloroacetic acid and 2 
volumes of acetone) was added and the mixture was 
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homogenized for 3-5 minutes. After incubation for six 
hours at room temperature, the precipitate was discarded 
and ovomucoid was precipitated from the supernatant by 
adding 2 - 2.5 volumes of cold acetone (with vigorous 
o 
stirring). The suspension was kept overnight at 4 C. The 
precipitate was recovered by centrifugation and then 
dissolved in glass distilled water. The crude ovomucoid 
thus precipitated was used for obtaining ovoinhibitor. A 
solution of crude ovomucoid (5%) was adjusted to pH 6.0 
with 1 N NaOH and the protein precipitated with 50% 
ammonium sulphate. The precipitated protein was dialyzed 
against 0.2 5% NaCl for overnight and the bag contents were 
centrifuged. The protein in .the supernatant was again 
precipitated with 35% ammonium sulphate. The precipitate 
was dialyzed against 0.1 M ammonium acetate buffer, pH 4.0 
and subjected to CM-cellulose chromatography (4 x 2.5 cm). 
The protein was eluted batchwise with 0.1 M ammonium 
acetate buffer, pH 4.9 and subsequently with 0.1 M 
ammonium acetate buffer, pH 5.0 containing 1 M NaCl. The 
protein in the latter fractions predominantly contained 
ovoinhibitor. The fractions containing ovoinhibitor were 
located using Suc-AAPF-pNA as substrate. 
11. Preparation of domain I 
The ovoinhibitor thus purified was subjected to 
cyanogen bromide cleavage for the isolation of domain I. 
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To a 50 ml glass stoppered conical flask wrapped with a 
carbon paper was added 0.4 g of CNBr and 4 ml of 80% (v/v) 
formic acid. The mixture was shaken for a few minutes and 
to it was added 26 ml of ovoinhibitor (previously dialyzed 
against 80% (v/v) formic acid) containing 0.2 g of 
protein. The contents were shaken thoroughly to get a 
homogeneous mixture. The final protein to CNBr ratio in 
the mixture thus became 1:2. After allowing the reaction 
mixture for 20 hr at room temperature, the excess reagents 
were removed by gel filtration on a Sephadex G-25 column 
(2.1 X 30 cm) previously equilibrated with 0.01 M sodium 
phosphate buffer, pH 7.6. The peak eluting with the void 
volume was pooled, concentrated and applied to a Sephadex 
G-75 column (2.4 X 86 cm) equilibrated with the same 
buffer. The protein fractions under the desired peak were 
pooled, concentrated and rechromato-graphed on the 
Sephadex G-75 column. 
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RESULTS 
A. Isolation/ purification and characterization of 
ovoinhibitor 
Crude ovomucoid was isolated from the eggs of white 
leg horn by the method of Kato et al. (1987) as described 
in the 'Experimental Section'. It was then subjected to 
salt fractionation and the ovoinhibitor rich fraction 
was further purified by CM-cellulose chromatography (see 
Fig. 9). The protein solution was loaded at pH 4.0 on a 
CM-cellulose column (2.5 x 4 cm) equilibrated with 0.1 M 
ammonium acetate buffer, pH 4.0. Some of the protein 
did not bind under these conditions and came out as flow 
through peak. The bound protein was eluted in a stepwise 
manner using 0.1 M ammonium acetate buffer, pH 4.9 and 
0.1 M ammonium acetate buffer, pH 5.0 containing 1 M 
NaCl. Out of the 60 mg protein applied to the column, 19% 
eluted in peak A and 65% eluted in peak B. Only peak B 
showed inhibitory activity against chymotrypsin whereas 
peak A showed negligible antichymotryptic activity. On the 
other hand, both peaks A and B showed strong antitryptic 
activity. The inhibitory activity was measured as 
described in the 'Experimental Section' using BAPNA and 
Suc-AAPF~pNA as substrates for trypsin and chymotrypsin 
respectively. These results strongly suggest that peak B 
contains ovoinhibitor whereas peak A contains ovomucoid 
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Fig. 9: Chromatographic profile of 35% ammonium sulphate 
fraction of crude ovomucoid on CM-cellulose 
column. 
About 60 mg of protein was applied to a 
CM-cellulose column (2.5 x 4 cm) equilibrated 
with 0.1 M ammonium acetate buffer, pH 4.0. The 
bound protein was eluted batchwise using 0.1 M 
ammonium acetate buffer, pH 4.9 and 0.1 M 
ammonium acetate buffer, pH 5.0 containing 1 M 
NaCl. FJ.actions of 3 ml each were collected at a 
flow rate of 5-20 ml/hr. The column was 
monitored by the method of Lowry et al. (1951). 
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since the latter inhibitor lacks antichymotryptic activity 
but possesses strong antitryptic activity. Fractions under 
the peak B indicated by a solid bar were pooled, 
concentrated and dialyzed against glass distilled water. 
The different steps involved in the preparation of 
ovoinhibitor from egg white along with the protein yield 
and the results on antitryptic and antichymotryptic 
activity at various stages of purification are summarized 
in Table IV. It can be seen that with respect to 
antichymotryptic activity, a 53 fold purification was 
obtained. Further, the procedure seems to be efficient 
as about 85% of the inhibitory activity is recovered. In 
contrast, the recovery with respect to antitryptic 
activity is" only about 2%. This is understandable since 
antitryptic activity is also shown by ovomucoid whose 
concentration in egg white far exceeds that of 
ovoinhibitor. 
Polyacrylamide gel electrophoretic pattern of pooled 
and concentrated peak B fractions obtained on 7% 
polyacrylamide gel at pH 8.2 is shown in Fig. 10. As can 
be seen, only one prominent protein band was obtained 
indicating charge homogeneity in the purified protein. 
Size exclusion chromatography of the inhibitor on a 
Sephadex G-75 column, equilibrated with 0.01 M sodium 
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TABLE IV 
PURIFICATION CHART OK OVOINHIBITOR FROM CHICKEN EGG WHITE ALONG WITH 
RESULTS ON ANTITRYPTIC AND ANT ICHYHOTRYPTIC ACTIVITIES AT VARIOUS 
LEVELS OF PURIFICATION 
Trypsin inhibitory activity Chymotrypsin inhibitory activity 
I solat ion 
sisps 
Total 
protein 
("iB> 
Protein 
yield 
(X) 
Total 
inhibition 
* 
uni ts 
Specific activity 
(Inhibition units 
per mg protein) 
Total Specific activity 
inhibition (Inhibition units 
units per mg protein) 
Ee3 Hhite 
Crude ovomucoid 
ZS'iZO 
1990 
100.00 
8.50 28429 U.3 2412 1.21 
50% ammonium 
sulphate fraction Zii* :.03 3486 14.3 4979 20.40 
35X anmonium 
sulphate fraction 77 0.32 1013 13.2 3208 41.70 
CM - cellulose 
fraction (Peak (I) 59 0.16 542 13.9 2052 52.60 
* An inhibition unit is an amount that gives 50X inhibition of 0.1 mg of enzyme. Total 
inhibition units were cbtained by dividing total protein with one inhibition unit. 
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Fig. 10: Polyacrylamide gel electrophoretic pattern 
of ovoinhibitor. 
About 100 ng of protein was electro-
phoresed in 7% gel for 3 hr in Tris -
glycine buffer, pH 8.2 (I = 0.02) using 
a current of 2-5 mA per tube. The gels 
were stained with amidoschwarz and 
destained mechanically with 7% acetic 
acid. 
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phosphate buffer, pH 7.6 gave a single symmetrical peak 
(see Fig. 11) . Further SDS~PAGE (described below) also 
gave a single protein band (see Fig, 17A). These results 
taken together clearly show that the inhibitor obtained 
after CM-cellulose chromatography is essentially pure. 
The ovoinhibitor preparation isolated in this study 
was found to be a sialoglycoprotein containing 5% neutral 
carbohydrate as determined by the method of Dubois et al. 
(1956) and 0.54% sialic acid as determined by the method 
of Warren (1959). The molecular weight of ovoinhibitor as 
determined by SDS-PAGE (Weber and Osborn, 1969) was found 
to be 53,000. The ultraviolet absorption spectrum of 
ovoinhibitor showed a maximum at 280 nm (see Fig. 12) . 
Further, the fluorescence excitation and emission maxima 
were found to occur near 280 nm and 3 38 nm respectively 
(see Fig. 13). 
B. Isolation and purification of domain I 
Cyanogen bromide cleaved protein was desalted on a 
Sephadex G-25 column (2.1 x 30 cm) equilibrated with 
0.01 M sodium phosphate buffer, pH 7.6. The protein 
fractions were pooled, concentrated and then fractionated 
on a Sephadex G-75 column (2.4 x 86 cm) equilibrated with 
the same buffer. The elution profile is shown in Fig. 14. 
Three protein peaks, A, B and C were obtained. The ratio 
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Fig. 11: Elution profile of ovoinhibitor on Sephadex G-75 
column. 
About 20 mg of protein was applied to the 
column (2.4 x 86 cm) equilibrated with 0.01 M 
sodium phosphate buffer, pH 7.6. The protein 
was eluted in 5 ml fractions at a flow rate of 
3 0 ml/hr and assayed by the method of Lowry et 
al. (1951). 
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Fig. 12: Ultraviolet absorption spectrum of ovoinhibitor. 
The ultraviolet absorption spectrum of 
ovoinhibitor (0.5 mg/ml) was recorded in 0.01 M 
sodium phosphate buffer, pH 7.6. 
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Fig. 13: Excitation (A) 
ovoinhibitor. 
and emission (B) spectra of 
Ovoinhibitor was taken in 0.01 M sodium 
phosphate buffer, pH 7.6 at a concentration of 
0.06 mg/ml. The spectra were recorded at room 
temperature using 10 nm slit. 
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Fig. 14: Chromatographic profile of cyanogen bromide digest of ovoinhibitor on Sephadex G-75 column. 
About 200 mg of protein digest was applied 
to the column (2.4 x 86 cm) equilibrated with 
0.01 M sodium phosphate buffer, pH 7.6. The 
protein was eluted at a flow rate of 30 ml/hr 
and fractions of 5 ml each were collected. The 
column was monitored by the method of Lowry et 
al. (1951) and the fractions under the bar {mma) 
were pooled and rechromatographed. 
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of the elution volume to the void volume of the column, 
Ve/Vo, determined for the three peaks and intact 
ovoinhibitor was 1.22, 1.34, 1.83 and 1.21 respectively. 
As judged by the gel filtration behaviour, peak A 
corresponds to uncleaved ovoinhibitor whereas peaks B and 
C represent the products of CNBr cleavage. Although 
ovoinhibitor contains five methionine residues, only one 
methionine (Met ) which connects domain I with domain II 
of ovoinhibitor lies outside the disulphide loop whereas 
all the other methionines are enclosed within disulphide 
loops. Thus one would theoretically expect that even if 
cleavage is taking place at all the methionine residues, 
only two fragments will be obtained, namely domain I and 
domain II to domain VII. The chromatographic profile is in 
exact accordance with this expectation. Thus peak B in 
Fig. 14 most likely contains a fragment consisting of 
domain II to VII with internal nicks at methionine 
residues and the protein under peak C probably 
represents domain I. The fluorescence excitation and 
emission spectra of pooled fractions under the peak C are 
shown in Fig. 20. Occurrence of excitation and emission 
maxima near 280 nm and 338 nm respectively is indicative 
of the presence of tryptophan. Since ovoinhibitor contains 
only one tryptophan (Trp-'-^ ) located in domain I (Scott 
et al., 1987), the fluorescence characteristics of peak C 
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fractions are in agreement with the fluorescence 
characteristics of domain I. Further evidence to this 
effect was provided by the amino acid analysis and 
molecular weight determination of protein under peak C, 
The molecular weight of protein under peak C as 
determined by SDS-PAGE was found to be 8,300 (see Table 
V) which is 12% higher than the value of molecular weight 
of domain I (7,300) deduced from amino acid sequence 
(Scott et al., 1987). As we shall see below, the amino 
acid composition of the protein under peak C is similar to 
that computed for domain I from amino acid sequence (Scott 
et al., 1987) . 
The relative yields of the three peaks A, B and C 
were 32%, 52% and 11% respectively. Thus from 200 mg of 
ovoinhibitor, 22 mg of domain I was obtained in this 
study. This yield is about 35% less than that (14.8%) 
expected from theory. 
Rechromatography of peak C on Sephadex G-75 column 
equilibrated with 0.01 M sodium phosphate bufffer, pH 7.6 
yielded a symmetrical elution profile (see Fig. 15), 
suggesting that the protein was homogeneous with respect 
to size. The presence of a single protein band in the 
electrophoretogram obtained by SDS-PAGE (see Fig. 17B) 
further showed size homogeneity of fraction C. The protein 
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Fig . 15i' Rechromatography of t h e cyanogen 
fragmfent C on Sephadex G-75 column. 
bromide 
About 10 mg of protein was applied to the 
column (2.4 X 86 cm) equilibrated with 0.01 M 
sodium phosphate buffer, pH 7.6. The protein 
was eluted at a flow rate of 30 ml/hr and 
fractions of 5 ml each were collected. The 
column was monitored by the method of Lowry et 
al. (1951). 
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was also homogeneous with respect to charge which is 
evident from a single protein band on electrophoresis in 
7% polyacrylamide gel (see Fig. 16). 
C. Characterization of domain I 
1. Molecular properties 
The molecular weight of domain I was determined by 
SDS-PAGE in 0.1 M sodium phosphate buffer, pH 7.0 
containing 0.1% (w/v) SD3 according to the method of Weber 
and Osborn (1969). The marker proteins namely ovalbumin, 
chymotrypsinogen A, ribonuclease A, cytochrome c and 
insulin along with domain I were electrophoresed under 
identical conditions. The electrophoretogram of domain I 
is shown in Fig. 17B. The relative mobilities of the 
marker proteins and domain I are listed in Table V. The 
difference between the molecular weight of A (2,340) and B 
(3,400) chains of insulin is small (1,060) (Croft, 1973) 
so that the two chains migrated as a single band under the 
conditions of our experiment and the average value of 
molecular weight was assumed and is given in Table V. 
A plot of log M versus I^ was obtained by the method 
of least squares and is given in Fig. 18; the curve fits 
the equation : 
log M = 5.48 - 2.05 R^ (9) 
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Fig. 16: Polyacrylamide gel electrophoretic pattern 
of domain I. 
About 80 ijg of protein was electro-
phoresed in 7% gel for 3 hr in Tris-
glycine buffer, pH 8.2 (I = 0.02) using 
a current of 2-5 mA per tube. The gels 
were stained with amidoschwarz and 
destained mechanically with 7% acetic 
acid. 
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Fig. 17: Sodium dodecyl sulphate polyacrylainide gel 
electrophoresis of ovoinhibitor (A) and 
domain I (B). 
About 60 ug of ovoinhibitor (A) and 
80 lag of domain I (B) was electrophoresed 
in-12.5% gel in the presence of 0.1 M 
sodium phosphate buffer, pH 7.0 
containing 0.1% SDS according to Weber 
and Osborn (1969) . The gels were 
stained with 0.2% coomassie brilliant 
blue R-250 dye and destained mechanically 
with 10% acetic acid. 
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TABLE V 
MOLECULAR WEIGHTS AND RELATIVE MOBILITIES OF MARKER 
PROTEINS AND DOMAIN I USED IN SODIUM DODECYL 
SULPHATE POLYACRYLAMIDE GEL ELECTROPHORESIS 
S.No. 
1. 
2. 
3. 
4. 
5. 
6. 
Proteita 
Ovalbumin 
Chymotryps inogen 
Ribonuclease 
Cytochrome c 
Insulin 
Domain 1 
A 
Molecular wei 
A 
43,000^ 
25,700^ 
13,700*^ 
11,700^ 
2,870® 
8,300^ 
.ght log M 
4.63 
4.41 
4.14 
4.07 
4.46 
-
Rm 
0.38 
0.54 
0.65 
0.78 
0.91 
0.76 
a. Castellino and Barker (1968). 
b. Tanford (1968). 
c. Eck and Dayhoff (1966). 
d. Weber and Osborn (1969). 
e. See text. 
f. This study. 
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Fig. 18: Plot of R^ values of marker 
logarithm of molecular weight. 
proteins versus 
The marker proteins were (1) ovalbumin (2) 
chymotrypsinogen A (3) ribonuclease A (4) 
cytochrome c and (5) insulin. The straight line 
computed by the help of least squares, fits the 
equation: 
log M = 5,48 - 2.05 Rj^  
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Corresponding to R^ of 0.76, the molecular weight of 
domain I was computed with the help of equation (9) to be 
8,300. Here, it should be pointed out that the Rj^^ was 
determined with a maximum error of 3% which yielded a 
maximum uncertainty in the molecular weight determination 
of 10%. The molecular weight of domain I determined in 
this study (8,300) is about 12% higher than that computed 
from amino acid composition (7,300). 
This discrepancy is not serious in view of the fact 
that the first domain of ovoinhibitior was found to 
contain 10% neutral carbohydrate as determined by the 
method of Dubois et al. (1956). In addition, domain I was 
also found to contain 2% sialic acid which was estimated 
by the method of Warren (1959). 
The ultraviolet absorption spectrum of domain I 
recorded in 0.01 M sodium phosphate buffer, pH 7.6 (see 
Fig. 19) showed a maximum at 280 nm. The fluorescence 
excitation and emission spectra of domain I are shown in 
Fig. 20. The excitation and emission maxima were found to 
occur near 280 nm and 33 8 nm respectively. These spectral 
features are in accordance with the fact that domain I 
contains one tryptophan. 
2. Amino acid composition 
The amino acid composition of domain I of 
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Fig. 19: Ultraviolet absorption spectrum of domain I. 
The ultraviolet absorption spectrum of 
domain I (0.3 mg/ml) was recorded in 0.01 M 
sodium phosphate buffer , pH 7.6. 
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Fig . 20; E x c i t a t i o n 
domain I . 
• (A) and emi s s ion (B) s p e c t r a of 
Domain I was t a k e n in 0 .01 M sodium 
phosphate buffer , pH 7.6 a t a concen t r a t i on of 
0.04 mg/ml. The spec t ra were recorded a t room 
tempeiature using 10 nm s l i t . 
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ovoinhibitor was determined by the procedure already 
described in the 'Experimental Section'. The results 
along with the expected values from amino acid- sequence 
are summarized in Table VI. In the calculation of amino 
acid composition of domain I, amino acid residues 1-66 of 
ovoinhibitor have been considered. The values are 
generally in good agreement with those expected from the 
amino acid sequence (Scott et al., 1987) within a maximum 
uncertainty of 10%. The agreement between the results 
obtained in this study and that expected from the sequence 
(see Table VI) is excellent for His, Arg, Gly, Thr, Leu 
and Phe and good to satisfactory for the rest of the 
amino acids excluding 1/2 cystine. The underestimation of 
serine and 1/2 cystine is understandable in view of their 
tendencies to undergo degradation during acid hydrolysis. 
The low value of methionine in this study could be 
attributed to the fact that domain I was obtained by 
cyanogen bromide cleavage. 
3. Hydrodynaaic properties 
The hydrodynamic parameters namely the Stokes radius 
and frictional ratio of domain I were determined by 
analytical gel chromatography on a Sephadex G-75 column 
(2.4 X 86 cm) equilibrated with 0.01 M sodium phosphate 
buffer, pH 7.6. 
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TABLE VI 
AMINO ACID COMPOSITION OF DOMAIN I 
Amino acid 
Number of eunino acid residues 
Expected* This study 
(Residues per mole) 
Asx 
Glx 
Ser 
Gly 
His 
Arq 
Thr 
Ala 
Pro 
Tyr 
Val 
Met 
1/2 Cys 
H e 
Leu 
Phe 
Lys 
Trp 
8 
5 
5 
8 
2 
3 
3 
3 
3 • 
4 
5 
1 
6 
2 
3 
0 
4 
1 
8 . 7 (9) 
5 . 5 (6) 
3 . 4 (3) 
7 . 6 (8) 
1 . 9 (2) 
2 . 7 (3) 
2 . 8 (3) 
4 . 3 (4) 
2 . 4 (2) 
2 . 5 (3) 
6 . 0 (6) 
0 . 2 (0) 
0 . 7 (1) 
3 . 2 (3) 
3 . 1 (3) 
0 . 3 (0) 
3 . 3 (3) 
N.D.*^ 
Total 66 60 
a. Calculated from sequence of ovoinhibitor (Scott et 
al., 1987). 
b. Number in parentheses are nearest integer values. 
c. Not determined. 
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The column was calibrated with the help of marker 
proteins listed in Table VII. The elution profiles of the 
marker proteins and domain I are depicted in Fig, 21-23. 
The distribution coefficient, K^ and the inverse error 
function complement of distribution factor of protein, 
erfc"-^ (1-K^) for the marker proteins and domain I were 
computed from their elution volumes and are listed in 
Table VIII. 
To determine the Stokes radius, r, of domain I, the 
gel filtration data were analyzed according to Ackers 
(1967) . Analysis of the results by the method of least 
squares, yielded a straight line (see Fig. 24) which obeys 
the equation ; 
r = 2.31 erfc"^(l-Kjj) + 0.42 (10) 
The value of erfc~-'-(l - K^) for domain I was found 
to be 0.55 which according to equation (10) corresponds to 
a Stokes radius of 1.7 nm. Here, it should be pointed out 
that this value of erfc~-'-(l - K^) is not covered by the 
range of erfc~'^(l - K^) found for marker proteins and it 
has been assumed that the extrapolation is corrrect to 
lower values of erfc~-'-(l - K^) . The error in the 
measurement of elution volume, which when introduced in 
the calculation, will amount to an error of 3% in the 
determination of Stokes radius. 
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TABLE VII 
MOLECULAR WEIGHTS AND STOKES RADII OF MARKER PROTEINS 
USED IN THE CALIBRATION OF SEFHADEX 6-75 COLUMN 
S.No. Protein Molecular weight Stokes radius 
(nm) 
1. Bovine serum albumin^ 69,000 3.5 
2. Ovalbumin^ 43,000 3.0 
3. Chymotrypsinogen A^ 25,700 2.2 
4. Myoglobin^ 17,800 1.9 
5. Cytochrome cp 11,700 1.7 
a. Tanford (1968). 
b. Castellino and Barker (1968). 
c. Weber and Osborn (1969). 
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02 
TOO V/^  130 160 140 
Elution volume, ml . 
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Fig. 21: Elution profiles of bovine serum 
ovalbumin on Sephadex G-75 column. 
albumin and 
About 20 mg of protein was applied to a 
Sephadex G-75 column (2.4 x 86 cm) equilibrated 
with 0.01 M sodium phosphate buffer, pH 7.6 and 
the protein was eluted in 5 ml fractions at a 
flow rate of 30 ml/hr. The column was monitored 
by the method of Lowry et al. (1951). 
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Fig. 22: E l u t i o n p r o f i l e s of chymot ryps inogen A and 
myoglobin on Sephadex G-75 column. 
The experimental cond i t ions were t h e same 
as given in the legend to Fig. 21 . 
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Fig. 23: Elution profiles of cytochrome c and domain I on 
Sephadex G--75 column. 
The experimental conditions were the same 
as given in the legend to Fig. 21. 
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TABLE VIII 
GEL FILTRATION DATA FOR THE MARKER PROTEINS AND 
DOMAIN I OBTAINED ON SEPHADEX 0-75 COLUMN 
S.No. Proteins v^ (ml) K^ I-K^ orfo"^ (X-Kfl) 
1. Bovine serum albumin 135 0.05 0.95 1.39 
2. Ovalbumin 160 0.16 0.84 1.01 
3. Chymotrypsinogen A 190 0.28 0.72 0.76 
4. Myoglobin 205 0.34 0.66 0.67 
5. Cytochrome c 220 0.41 0.59 0.59 
6. Domain I 225 0.43 0.57 0.55 
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Fig. 2<: Plot of the gel filtration data for the marker 
proteins according to the theoretical treatment 
of Ackers (1967). 
The marker proteins used were ; (1) bovine 
serurn "albumin (2) ovalbumin (3) chymotrypsino-
gen A (4) myoglobin and (5) 
straight line computed by 
squares, fits the equation ; 
cytochrome £. The 
the help of least 
r = 2.31 [Grfc~^(l-K^)] +0.42 
7 3 
The frictional ratio, f/f^ of domain I was calculated 
using the relation (Siegel and Monty, 1966) : 
f/fQ = r/(3V^M/47^)^/^ (11) 
where N is the Avagadro's number (6.023 x 10^ -^  per mole). 
V2 is the partial specific volume of protein in ml/g and 
M is the molecular weight. The partial specific volume of 
domain I was taken to be the same as that (0.707 ml/g) 
actually found for ovoinhibitor by density measurements 
(Davis et al., 1969) and the molecular weight was taken as 
8,3 00 as determined by SDS-PAGE. Using these values, the 
f/f^ of domain I was calculated as 1.28, suggesting that 
domain I possesses somewhat asymmetric overall confor-
mation. 
4. Functional properties 
The inhibitory activity of ovoinhibitor and domain I 
was measured against four proteinases namely bovine 
trypsin, bovine chymotrypsin, porcine elastase and 
proteinase K in 0.1 M Tris-HCl buffer, pH 8.0 containing 
0.01 M CaCl2. The stoichiometry of the reactions between 
the enzymes and domain I (or ovoinhibitor) was determined 
by incubating a constant amount of enzyme with varying 
concentrations of inhibitor for 3 0 minutes at 37 C and 
measuring the residual activity as described in the 
'Experimental Section'. The results are depicted in 
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Fig. 25-28. Ovoinhibitor inhibited all the four enzymes, 
whereas domain I was active only against trypsin. Domain I 
was virtually devoid of activity against chymotrypsin, 
elastase and proteinase K. For chymotrypsin, the 
stoichiometry of ovoinhibitor-enzyme binding was about 
0.5, whereas for elastase and proteinase K, the stoichio-
metry was about 1. This is in accordance with previous 
results (Gertler and Ben Valid, 1980; Gertler and 
Feinstein, 1971; Davis et al., 1969). Complete inhibition 
of trypsin was achieved at an inhibitor to enzyme molar 
ratio of 0.5 for ovoinhibitor and 1 for domain I suggest-
ing that there are at least two trypsin inhibitory sites 
in ovoinhibitor, one of which is located in domain I. 
Because of steric reasons the actual number of trypsin 
inhibitory sites in ovoinhibitor may be more than the two 
observed experimentally. 
Time course of reaction 
As stated above, complete inhibition of trypsin by 
domain I was achieved at an inhibitor to enzyme molar 
ratio of about 1 (see Fig. 25) . For studies on time 
course of inactivation of trypsin by domain I, an 
aliquot of 1 ml sample was withdrawn at different time 
intervals from a mixture containing equimolar concen-
trations (2.2 X 10'^ M) of enzyme and domain I and the 
residual activity measured as before. The decrease in 
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"5 
V> 
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0.6 
[Inhibitor ] 
[Trypsin] 
Fig. 25: Stoichiometry of binding of ovoinhibitor and 
domain I to bovine trypsin. 
A fixed concentration of trypsin (110 nM) 
was incubated with different concentrations (11 
nM to 110 nM) of ovoinhibitor (o) and domain I 
(•) for 3 0 minutes at 37*^0. The residual 
enzyme activity was measured according to the 
method of Erlanger et al. (1961) using BAPNA 
as substrate. 
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Fig. 26: Stoichiometry of binding of ovoinhibitor and 
domain I to bovine chymotrypsin. 
A fixed concentration of chymotrypsin (110 nW 
was incubated with different concentration 
(11 nM to 110 nM) of ovoinhibitor (o) an 
domain !(•) for 30 minutes at 37°C. The residua 
enzyme 
method 
pNA as 
M) 
s 
d 
l 
activity was measured according to the 
of Del Mar et al. (1979) using Suc-AAPF— 
substrate. 
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Fig. 27: Stoichiometry of binding of ovoinhibitor and 
domain I to porcine elastase. 
A fixed concentration of elastase (110 nM) 
v/as incubated v/ith different concentrations 
(99nM to 198 nM) of ovoinhibitor (o) and 
domain I (•) for 30 minutes at 37° C. The 
residual caseinolytic activity was measured 
according to the method of Anson (1938) using 
0.5% casein as substrate. 
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[ Proteinase K ] 
Fig. 28: Stoichiometry of binding of ovoinhibitor and 
domain I to proteinase K. 
A fixed concentration of proteinase K (110 
nM) was incubated with different concentrations 
(55 nM to 154 nM) of ovoinhibitor (o) and 
domain I (•) for 30 minutes at 37 C.The residual 
caseinolytic activity was measured according to 
the method of Anson (1938) using 0.5% casein as 
substrate. 
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activity followed the curve shown in Fig. 29. As can be 
seen, maximum inhibition was achieved within 5 minutes of 
incubation period suggesting rapid association of domain I 
with trypsin. 
Equilibrium constant 
Domain I of ovoinhibitor is a Kazal type of 
inhibitor (Scott et al., 1987) and therefore is expected 
to follow the standard mechanism of inhibition. The 
dissociation of enzyme inhibitor complex (EI) can be 
represented as : 
EI ^ •>- I + E (12) 
where I is the inhibitor (domain I) and E is the enzyme 
being inhibited. The dissociation constant represented 
as: 
[I] [E] 
Kd = (13) 
[EI] 
was determined by the enzyme titration method of Green and 
Work (1953) with some modifications. The titration curve 
of domain I with trypsin was repeated with a more dilute 
concentration of trypsin (2.2 x 10~^ M) , a condition 
required for the detection of free enzyme and the 
dissociation constant subsequently determined by 
investigating the inhibition curve near the equivalence 
point (see Fig. 30). The residual tryptic activity in 
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Time, min 
Fig. 29: Residual enzyme activity versus 
of domain I with trypsin. 
incubation time 
Residual enzyme activity was measured on 
aliquots withdrawn at different time intervals 
from ? mixture of inhibitor and enzyme (molar 
ratio 1:1) kept at 37°C for 30 minutes. The 
residual enzyme activity was measured as 
described in the legend to Fig, 25. 
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Fig. 30: Titration of trypsin with domain I for the 
determination of dissociation constant. 
,-8 
A dilute concentration of enzyme (2.2 x 
10~° M) was incubated with different concentra-
tions (0.55 X 10"^ M - 4.4 X 10"^ M) of domain I 
at-pH 8.0 for 30 minutes and the residual enzyme 
activity measured as described in the legend to 
Fig.25. 
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presence of one equivalent of inhibitor was used to 
calculate an approximate dissociation constant as 
described below. 
First, a plot of tryptic activity versus enzyme 
concentration was obtained (see Fig. 31). The slope (m) of 
this curve was computed to be 3.6 x 10^ O.D.unit/min/mole. 
Using this value of slope, it was possible to calculate 
the enzyme concentration from the measured value of 
activity. 
The dissociation constant, K^ j, can be represented in 
terms of activity as : 
At 1 
Kd = X (14) 
(AQ - A^) m 
where A^ is the activity in absence of inhibitior and A^ 
is the activity in presence of inhibitor. From the results 
on activity of trypsin, measured both in absence and 
presence of one equivalent of domain I (see Fig. 30), the 
dissociation constant for domain I - bovine trypsin 
complex was computed to be 1.5 x 10"^ M at pH 8.0. 
Further, the dissociation constant, K^, was 
determined under different experimental conditions of pH, 
ionic strength and urea concentrations listed in Table 
IX. The dissociation constant showed little dependence 
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Fig. 31: Dependence of enzyme activity of bovine trypsin 
on enzyme concentration. 
The activity of trypsin was determined at 
different concentrations of enzyme (1.1 x 10 M 
- 5.5 X 10"^ M) in 0.1 M Tris-HCl buffer,pH 8.0 
containing 0.01 M CaCl2 using BAPNA as 
substrate. The slope of the plot was computed to 
be-3.6 X 10 O.D. unit/min/mole. 
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TABLE IX 
EFFECT OF pH, IONIC STRENGTH AND UREA CONCENTRATION 
ON THE DISSOCIATION CONSTANT OP DOMAIN I 
KJ(X10"'M) 
pH 
6.0 0.5 
7.0 5.2 
8.0 1.5 
Ionic strength 
0.05 5.6 
0.1 3.3 
0.2 0.2 
Urea (M) 
2 3.3 
4 7.8 
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on pH and ionic strength, suggesting that the. complex is 
very stable. This was further supported by the results on 
K^ measurements in presence of urea. Since urea is 
expected to increase the dielectric constant (Dill, 1990), 
we expected a substantially higher value for the 
dissociation constant. However, the values of K^ in 
presence of urea were of the same order of magnitude to 
those found in absence of urea. 
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DISCUSSION 
Ovoinhibitor is a seven domain, glycoprotein, 
multiheaded serine proteinase inhibitor (Scott et al., 
1987). The isolation procedure of ovoinhibitor is well 
established (Matsushima, 1958; Tomimatsu et al., 1966; 
Davis et al., 1969). In this study, the inhibitor was 
isolated from chicken egg white using a combination of 
salt fractionation and ion - exchange chromatography. 
Ovoinhibitor was distinguished from ovomucoid, the major 
proteinase inhibitor found in egg white on the basis of 
its size, fluorescence characteristics and inhibitory 
properties. The inhibitor, isolated in this study, gave a 
molecular mass of 53 kD in SDS-PAGE which is substan-
tially higher than that of ovomucoid (28 kD) (Rhodes et 
al., 1960). Further, the fluorescence spectral features 
of the isolated protein (see Fig. 13) suggested the 
presence of tryptophan which is consistent with the fact 
that ovoinhibitor contains a single tryptophan residue 
(Scott et al., 1987). Ovomucoid, on the other hand, is 
known to be devoid of tryptophan (Feeney and Allison, 
1969). Finally, ovoinhibitor showed strong antichymo-
tryptic activity unlike ovomucoid which lacks inhibitory 
activity against chymotrypsin (Ryan et al., 1965). 
The ovoinhibitor preparation was found to be 
homogeneous both with respect to size and charge as 
indicated by SDS-PAGE (see Fig. 17A), analytical gel 
chromatography (see Fig. 11) and PAGE under native 
conditions (see Fig. 10) . The isolated inhibitor had 
expected neutral carbohydrate (5%) and sialic acid (0.54%) 
content. 
Extensive studies have been done on ovomucoid third 
domains (Kato et al., 1987; Laskowski et al., 1987; 
Laskowski et al., 1990) which are structurally similar 
to the seventh domain of ovoinhibitor. However, very 
little has been done on the other two domains of ovomucoid 
which are structurally similar to domain I - VI of 
ovoinhibitor. The only structural difference between 
domain III of ovomucoid and its other two domains (or 
domain VII of ovoinhibitor and its other domains) is of a 
nine residue segment between Pg and P^  in the disulphide 
enclosed loop containing the reactive site. Because of the 
non availability of structural and inhibitory properties 
on these domains, it is difficult to guess the role of 
this insertion in the structure and function of these 
domains. This lack of information is primarily because of 
difficulties involved in the preparation of intact domain 
I and II of ovomucoid (Kato et al., 1978). For instance, 
even in careful studies, the preparation of these domains 
by proteolytic enzymes, intra-nicking of peptide bonds is 
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difficult to avoid. This problem is, however, minimized 
in the preparation of the first domain of ovoinhibitor 
68 
because of the presence of a methionine (Met ) between 
domain I and II which renders it susceptible to specific 
chemical cleavage. 
In this study, cyanogen bromide cleavage of 
ovoinhibitor followed by repeated gel filtration yielded 
a preparation of domain I which was homogeneous with 
respect to size and charge as indicated by PAGE under 
native conditions (see Fig. 16), SDS-PAGE (see Fig. 17B) 
and gel filtration behaviour (see Fig. 15) . Three protein 
peaks A, B, and C were obtained on fractionating the 
cyanogen bromide digest on Sephadex G-75 column (see Fig. 
14) . As judged by the gel filtration behaviour, peak A 
corresponds to intact ovoinhibitor whereas peaks B and C 
represent the products of cyanogen bromide cleavage. 
Since ovoinhibitor contains five methionine residues, one 
would expect six peptides after cyanogen bromide 
cleavage. However, except Met^^ which is located between 
domain I and II, all other methionines are enclosed within 
disulphide loops. Therefore, even if peptide bond cleavage 
is taking place on these methionine residues, the various 
peptides would remain linked to each other as long as the 
disulphide bonds are intact. Thus only two fragments 
should be obtained namely domain I and domain II-VII. The 
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chromatographic profile is in accordance with this 
expectation. Thus peak B fractions most probably contain 
domain II - VII with internal nicks at methionine residues 
and peak C contains domain I. The protein under the 
desired peak was identified as domain I on the basis of 
its fluorescence characteristics. It should be pointed 
out that ovoinhibitor contains a sole tryptophan residue, 
which is located in its first domain. Occurrence of 
excitation and emission maxima (see Fig. 21) near 280 nm 
and 338 nm respectively is consistent with the presence of 
tryptophan in domain I. Additional evidence regarding the 
identity of domain I was provided by the results on amino 
acid composition and molecular weight determination. The 
yield of domain I was about 11% which is close to that 
expected from theory (14.8%). 
The amino acid composition of domain I isolated in 
this study (see Table VI) was similar to that computed 
from amino acid sequence (Scott et al., 1987). The 
molecular weight of domain I as determined by SDS-PAGE was 
found to be 8,300 which is 12% higher than that computed 
from amino acid sequence (Scott et al., 1987). This 
discrepancy has been ascribed to the glycoprotein nature 
of domain I which was found to contain 10% neutral 
carbohydrate and 2% sialic acid. Such discrepancies have 
also been observed earlier for glycoproteinase inhibitors 
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like ovomucoid (Waheed, 1974; Waheed and Salahuddin, 
1975) and inhibitor from horse seminal plasma (Pellegrini 
and Follenberg, 1980). 
The hydrodynamic parameters of domain I, as deter-
mined from its gel filtration behaviour on a calibrated 
Sephadex G-75 column, were consistent with a Stokes 
radius of 1.7 nm and a frictional ratio of 1.28 suggesting 
asymmetry and/or excessive hydration of the inhibitor 
molecule. This explanation appears plausible since domain 
I, being a glycoprotein containing 10% carbohydrate, is 
likely to be substantially hydrated. 
As discussed in the 'Introduction', ovoinhibitor is 
known to possess inhibitory activity against several 
proteinases (Rhodes et al., 1960; Ryan and Clary, 1984; 
Haynes and Feeney, 1967; Gertler and Feinstein, 1971; Birk 
et al., 1983). Our results on the inhibition of bovine 
trypsin, bovine chymotrypsin, porcine elastase and 
proteinase K (see Fig. 25-28) suggested that domain I 
possesses distinctly different inhibitory activity. While 
all the four proteinases were inhibited at appropriate 
molar ratio of ovoinhibitor to enzyme, domain I was 
effective only against trypsin. Unlike the first domain of 
chicken ovomucoid (Nagata and Yoshida, 1984), domain I of 
ovoinhibitor shows strong antitryptic activity. The 
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equilibrium dissociation constant, K^ ,^ for domain I -
—9 
trypsin complex was computed to be 1.5 x 10 ^ M at pH 8.0 
(see Fig. 30) which is equivalent to an association 
constant, K^, of 6.6 x 10^ M"^. 
The inhibitory activity of a protein proteinase 
inhibitor is believed to be solely determined by the 
reactive site region which extends from Pg to P3' 
(Fujinaga et al., 1982). The specificity of the inhibitor 
strongly depends upon the amino acid present at the P2 
position (Ardelt and Laskowski, 1985). For instance, 
inhibitors containing Tyr or Phe at P^^ position aire strong 
inhibitors of chymotrypsin whereas those containing Arg 
and Lys at P, are strong inhibitors of trypsin. The amino 
acid sequence of the reactive site region of the first 
domain of ovoinhibitor (OICHIl) along with the sequence of 
four other trypsin inhibitors is shown in Fig. 32. The 
trypsin inhibitory activity of the first domain of 
ovoinhibitor is consistent with the presence of Arg at P^^ 
position. The association constant values against trypsin 
for the five inhibitors are also shown in Fig. 32. The 
strongest of tnese trypsin inhibitors is bovine pancreatic 
trypsin inhibitor (BPTI) with a K^ of 1.8 x lO"'--^  M"^. The 
first domain of ovoinhibitor is moderately strong having 
an association constant of 6,6 x 10^ M"-^ . The difference 
in the association constants of these two inhibitors is 
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Inhibitor Reactive si te 
OMCHIl 
0MCHI2 
BPTI 
BPSTI 
O I C H I l 
P P P P P P 
V L V C N K 
M V L C N R 
V T G P C K 
V N G C P R 
W V A C P R 
P P P 
\ 2 3 
D L R 
A F N 
A R I 
I Y N 
N L K 
Association constont 
3.Ox 10^ 
Reference 
1.0 X 10 10 
1 . 8 x 1 0 13 
10 3.Ox 10 
6 . 6 x 10^ 
Nogata and Yoshida, 1984. 
Kato et a l . ,1987. 
Vincent and Lazdunsk i , 1972 
Schweitz et a l . ,1973 . 
This study. 
Fig. 32: A comparison of the amino acid sequence of the 
r e a c t i v e s i t e region and the a s s o c i a t i o n 
equi l ibr ium cons tan ts of some t r y p s i n 
inh ib i to r s . 
The abbreviations refer to : OMCHIl 
chicken ovomucoid f i r s t domain; 0MCHI2 
chicken ovomucoid second domain; BPTI bovine 
pancreatic trypsin inhibi tor (Kunitz); BPSTI 
bovine pancreatic secretory t rypsin inh ib i to r 
(Kazal) and OICHIl chicken o v o i n h i b i t o r 
f i r s t domain (Kazal). 
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difficult to discuss in terms of structure because of 
several differences in the primary structure of their 
reactive sites. However, bovine pancreatic secretory 
trypsin inhibitor (BPSTI) which like the first domain of 
ovoinhibitor is a Kazal type of inhibitor shows a good 
degree of similarity in the reactive site region 
particularly in the P^  to P^^ region; the only difference 
in this region being at P^  where a Gly in BPSTI is 
substituted by Ala in OICHIl. There are however certain 
important differences in the P^^ to P3 region, the most 
important being at P-j^  where an Asn in OICHIl is replaced 
by lie in BPSTI. Association constant measurements of 
BPSTI against trypsin have not been performed in this 
study. However, comparison of the K^ value of BPSTI 
reported earlier (Schweitz et al., 1973) with the K^ value 
of OICHIl (6.6 X 10^ M"-^  ) found in this study shows a 45 
fold difference in the association constant. This 
difference can presumably be accounted for by the 
differences at P^  to P3 region. The data base at our 
hand is too short to make any detailed analysis but it is 
hoped that K^ measurements against different domains of 
chicken ovoinhibitor and other inhibitors of known 
sequences would give a better understanding of the 
sequence to reactivity relation in these trypsin 
inhibitors. 
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